13F-HR filed by Vestal Point Capital, LP
Vestal Point Capital, LP filed this 13F-HR for the quarter ended 2023-12-31, filed 2024-02-13, with 48 holding rows worth $943,958,964.
- Accession
- 0001974915-24-000002
- Filer
- CIK 1974915
- Filed
- 2024-02-13
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2023
A holdings report, 48 entries on the cover page, a total value of $943,958,964 stated on the cover page (in dollars after the unit check, H1), rows summing to $943,958,964 with VALUE read as dollars as filed, 13F file number 028-23784. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| NEUROCRINE BIOSCIENCES INC | 64125C109 | COM | 800,000 | $105,408,000 | dollars as filed | |
| JAZZ PHARMACEUTICALS PLC SHS USD | G50871105 | Stock | 725,000 | $89,175,000 | dollars as filed | |
| ASCENDIS PHARMA A/S DKK 1.0 AD | 04351P101 | SPONSORED ADR | 625,000 | $78,718,750 | dollars as filed | |
| INHIBRX INC | 45720L107 | COM | 1,530,000 | $58,140,000 | dollars as filed | |
| SOLENO THERAPEUTICS INC | 834203309 | COM | 1,300,000 | $52,325,000 | dollars as filed | |
| Merck & Co.,Inc. | 58933Y105 | COM | 400,000 | $43,608,000 | dollars as filed | |
| GLOBUS MED INC CL A | 379577208 | Stock | 800,000 | $42,632,000 | dollars as filed | |
| PACIRA BIOSCIENCES INC COM | 695127100 | Stock | 1,200,000 | $40,488,000 | dollars as filed | |
| CYMABAY THERAPEUTICS INC | 23257D103 | COM | 1,625,000 | $38,382,500 | dollars as filed | |
| VAXCYTE INC COM | 92243G108 | Stock | 525,000 | $32,970,000 | dollars as filed | |
| INSMED INC COM PAR $.01 | 457669307 | Stock | 900,000 | $27,891,000 | dollars as filed | |
| UNIQURE NV | N90064101 | SHS | 3,925,000 | $26,572,250 | dollars as filed | |
| ALX ONCOLOGY HOLDINGS INC | 00166B105 | COMMON STOCK | 1,655,000 | $24,642,950 | dollars as filed | |
| IMMATICS N.V | N44445109 | SHS | 2,100,000 | $22,113,000 | dollars as filed | |
| VIRIDIAN THERAPEUTICS INC | 92790C104 | COM | 1,000,000 | $21,780,000 | dollars as filed | |
| REVOLUTION MEDICINES INC COM | 76155X100 | Stock | 725,000 | $20,793,000 | dollars as filed | |
| BIOGEN INC COM | 09062X103 | Stock | 75,000 | $19,407,750 | dollars as filed | |
| EDWARDS LIFESCIENCES CORP COM | 28176E108 | Stock | 225,000 | $17,156,250 | dollars as filed | |
| ASTRAZENECA PLC SPONSORED ADR | 046353108 | ADR | 250,000 | $16,837,500 | dollars as filed | |
| CRINETICS PHARMACEUTICALS INC COM | 22663K107 | Stock | 450,000 | $16,011,000 | dollars as filed | |
| LYRA THERAPEUTICS INC | 55234L105 | COM | 3,000,000 | $15,720,000 | dollars as filed | |
| SANOFI SA SPONSORED ADR | 80105N105 | ADR | 300,000 | $14,919,000 | dollars as filed | |
| NUVALENT INC COM | 670703107 | Stock | 200,000 | $14,718,000 | dollars as filed | |
| Applied Therapeutics Inc | 03828A101 | Common Stock | 4,155,000 | $13,919,250 | dollars as filed | |
| LIQUIDIA CORPORATION COM NEW | 53635D202 | Stock | 1,025,000 | $12,330,750 | dollars as filed | |
| AEROVATE THERAPEUTICS INC | 008064107 | COM | 400,000 | $9,052,000 | dollars as filed | |
| REGENERON PHARMACEUTICALS COM | 75886F107 | Stock | 10,000 | $8,782,900 | dollars as filed | |
| ARCUTIS BIOTHERAPEUTICS INC | 03969K108 | COM | 2,700,000 | $8,721,000 | dollars as filed | |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 175,000 | $8,060,500 | dollars as filed | |
| FULCRUM THERAPEUTICS INC | 359616109 | COMMON STOCK | 1,025,000 | $6,918,750 | dollars as filed | |
| ALNYLAM PHARMACEUTICALS INC COM | 02043Q107 | Stock | 35,000 | $6,699,350 | dollars as filed | |
| LAKEFRONT BIOTHERAPEUTICS NV | 36315X101 | SPON ADR | 130,000 | $5,284,500 | dollars as filed | |
| FATE THERAPEUTICS INC | 31189P102 | COM | 1,290,000 | $4,824,600 | dollars as filed | |
| CYTOKINETICS INC | 23282W605 | COM NEW | 50,000 | $4,174,500 | dollars as filed | |
| ARCELLX INC COMMON STOCK | 03940C100 | Stock | 60,000 | $3,330,000 | dollars as filed | |
| BLUEBIRD BIO INC | 09609G100 | COM | 2,150,000 | $2,967,000 | dollars as filed | |
| TEVA PHARMACEUTICAL INDS LTD SPONSORED ADS | 881624209 | ADR | 200,000 | $2,088,000 | dollars as filed | |
| DIANTHUS THERAPEUTICS INC | 252828108 | COM | 135,000 | $1,404,000 | dollars as filed | |
| CHIMERIX INC COM | 16934W106 | Stock | 1,400,000 | $1,347,500 | dollars as filed | |
| PYXIS ONCOLOGY INC COMMON STOCK | 747324101 | Stock | 440,000 | $792,000 | dollars as filed | |
| RENEO PHARMACEUTICALS INC | 75974E103 | COM | 400,000 | $640,000 | dollars as filed | |
| IKENA ONCOLOGY INC | 45175G108 | COM | 322,671 | $635,662 | dollars as filed | |
| RELMADA THERAPEUTICS INC | 75955J402 | COMMON STOCK | 115,000 | $476,100 | dollars as filed | |
| AFFIMED N V | N01045108 | COM | 546,067 | $341,292 | dollars as filed | |
| OVID THERAPEUTICS INC | 690469101 | COMMON STOCK | 85,429 | $275,081 | dollars as filed | |
| SOLID BIOSCIENCES INC | 83422E204 | COMMON STOCK | 34,085 | $209,282 | dollars as filed | |
| PRIME MEDICINE INC | 74168J101 | COM | 20,306 | $179,911 | dollars as filed | |
| ACHILLES THERAPEUTICS PL-ADR | 00449L102 | COM | 108,083 | $96,086 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001974915-24-000002 | this filing | 2024-02-13 | acceptance time not in the bulk data set |